Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 4Tuberous Sclerosis 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Leukemia 2Hematologic Neoplasms 2Graft vs Host Disease 2Carcinoma, Non-Small-Cell Lung 2Advanced Solid Tumors 2Skin Neoplasms 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Perivascular Epithelioid Cell Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Melanoma 1Malignant Solid Tumors 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Gastroenteropancreatic Neuroendocrine Tumors 1Fibroma 1Facies 1Exanthema 1Erythema 1Colorectal Neoplasms 1

Interventions

fludarabine phosphate 4fludarabine 3Mycophenolic Acid 3Filgrastim 3Cytarabine 3Cyclophosphamide 3revumenib 2Whole-Body Irradiation 2Mesna 2Bone Marrow Transplantation 2pegaspargase 1Vincristine 1Thiotepa 1Stem Cell Transplantation 1Standard of Care 1Sirolimus 1Midazolam 1Melphalan 1MRX-2843 1Itraconazole 1Granulocyte Colony-Stimulating Factor 1Fentanyl 1Dexamethasone 1Cyclosporine 1Cord Blood Stem Cell Transplantation 1Cobicistat 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Leukemia, Biphenotypic, Acute × Sirolimus × Clear all
NCT05170828 2026-02-24

Cryopreserved MMUD BM With PTCy for Hematologic Malignancies

Ossium Health, Inc.

Phase 1 Withdrawn
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡